Immune checkpoint proteins are molecules that generate co-stimulatory or co-inhibitory signals during immune responses, relevant in cancer immunotherapy research. These proteins are targets for therapies designed to modulate the immune system, enhancing its ability to recognize and destroy cancer cells while minimizing damage to normal tissues. At CymitQuimica, we offer a wide range of immune checkpoint proteins to support your immunotherapy research and development efforts.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.